Nuclear factor-κB p65 mediates the assembly and activation of the TNF- responsive element of the murine monocyte chemoattractant-1 gene

Journal of Immunology

Volumn 162, Issue 2, 1999, Pages 727-734

  Ping, Dongsheng ^a   Boekhoudt, Gunther H ^a   Rogers, Edward M ^a   Boss, Jeremy M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; FIBROBLAST; GENE ACTIVATION; GENE INDUCTION; IMMUNOREGULATION; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DNA INTERACTION;

3T3 CELLS; ANIMALS; ANTIOXIDANTS; CHEMOKINE CCL2; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, INBRED BALB C; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; PROTEIN ISOFORMS; PYRROLIDINES; SEQUENCE ALIGNMENT; THIOCARBAMATES; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033555787     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Baggiolini, M., B. Dewald, and B. Moser. 1997. Human chemokines: an update. Annu. Rev. Imnmnol. 15:675.
2. Rahimi, P., C.-Y. Wang, P. Stashenko, S. K. Lee, J. A. Lorenzo, and D. T. Graves. 1995. Monocyte chemoattractant protein-1 expression and monocyte recruitment in osseous inflammation in the mouse. Endocrinology 136:2752.
3. Ransohoff, R. M. 1997. Chemokines in neurological disease models: correlation between chemokine expression patterns and inflammatory pathology. J. Leukocyte Biol. 62:645.
4. Ping, D., P. L. Jones, and J. M. Boss. 1996. TNF regulates the in vivo occupancy of both distal and proximal regulatory regions of the murine monocyte chemoattractant protein-1 (MCP-1/JE) gene. Immunity 4:455.
5. Rollins, B. J. 1991. JE/MCP-1: an early-response gene encodes a monocyte-specific cytokine. Cancer Cell 3:517.
6. Gibran, N. S., M. Ferguson, D. M. Heimbach, and F. F. Isik. 1997. Monocyte chemoattractant protein-1 mRNA expression in the human burn wound. J. Surg. Res. 70:1.
7. Shyy, J. Y.-J., Y.-S. Li, M.-C. Lin, W. Chen, S. Yuan, S. Usami, and S. Chien. 1995. Multiple cis-elements mediate shear stress-induced gene expression. J. Biomechanics 28:1451.
8. Faller, D. V., H. Weng, D. T. Graves, and S.-Y. Choi. 1997. Moloney murine leukemia virus long terminal repeat activates monocyte chemotactic protein-1 protein expression and chemotactic activity. J. Cell. Physiol. 172:240.
9. Howard, O. M. Z., A. Ben-Baruch, and J. J. Oppenheim. 1996. Chemokines: progress toward identifying molecular targets for therapeutic agents. Trends Biotechnol. 14:46.
10. Ransohoff, R. M., A. Glabinski, and M. Tani. 1996 Chemokines in immune-mediated inflammation of the central nervous system. Cytokine Growth Factor Rev. 7:35.
11. Brown, Z., R. L. Robson, and J. Westwick. 1996. Regulation and expression of chemokines: potential role in glomerulonephritis. J. Leukocyte Biol. 59:75.
12. Baggiolini, M., and C. A. Dahinden. 1994. CC chemokines in allergic inflammation. Immunol. Today 15:127.
13. Luster, A. D., and M. E. Rothenberg. 1997. Role of the monocyte chemoattractant protein and eotaxin subfamily of chemokines in allergic inflammation. J. Leukocyte Biol. 62:620.
14. Lioyd, C. M., M. E. Dorf, A. Proydfoot, D. J. Salant, and J.-C. Gutierrez-Ramos. 1997. Role of MCP-1 and RANTES in inflammation and progression to fibrosis during murine crescentic nephritis. J. Leukocyte Biol. 62:676.
15. Singh, P. K., and I. J. Fidler. 1993. Synergism between human recombinant monocyte chemotactic and activating factor and lipopolysaccharide for activation of antitumor properties in human blood monocytes. Lymphokine Cytokine Res. 12:285.
16. Weiss, L., A. Si-Mohamed, P. Giral, P. Castiel, A. Ledur, C. Blondin, M. D. Kazatchkine, and N. Haeffner-Cavaillon. 1997. Plasma levels of monocyte chemoattractant protein-1 but not those of macrophage inhibitory protein-1a and RANTES correlate with virus load in human immunodeficiency virus infection. J. Infect. Dis. 176:1621.
17. Sozzani, S., M. Introna, S. Bernasconi, N. Polentarutti, P. Cinque, G. Poli, A. Sica, and A. Mantovani. 1997. MCP-1 and CCR2 in HIV infection: regulation of agonist and receptor expression. J. Leukocyte Biol. 62:30.
18. Schwartz, C. J., A. J. Valente, E. A. Sprague, J. L. Kelley, and R. M. Nerem. 1991. The pathogenesis of atherosclerosis: an overview. Clin. Cardiol. 14:1-1.
19. Tracey, K. J., and A. Cerami. 1994. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu. Rev. Med. 45:491.
20. Van Antwerp, D. J., S. J. Martin, T. Kafri, D R. Green, and I. M. Verma. 1996. Suppression of TNF-α-induced apoptosis by NF-κB. Science 274:787.
21. Wang, C.-Y., M. W. Mayo, and A. S. Baldwin. 1996. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274:784.
22. Beg, A. A., and D. Baltimore. 1996. An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274:782.
23. Strieter, R. M., S. L. Kunkel, and R. C. Bone. 1993. Role of tumor necrosis factor-α in disease states and inflammation. Crit. Care Med. 21:S447.
24. Tracey, K. J., and A. Cerami. 1993. Tumor necrosis factor, other cytokines and disease. Annu. Rev. Cell Biol. 9:317.
25. Beutler, B., and G. E. Grau. 1993. Tumor necrosis factor in the pathogenesis of infectious diseases. Crit. Care Med. 21:S423.
26. Ueda, A., K. Okuda, S. Ohno, A. Shirai, T. Igarashi, K. Matsunaga, J. Fukushima, S. Kawamoto, Y. Ishigatsubo, and T. Okubo. 1994. NF-κB and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J. Immunol. 153:2052.
27. Ueda, A., Y. Ishigatsubo, T. Okubo, and T. Yoshimura. 1997. Transcriptional regulation of the human monocyte chemoattractant protein-1 gene. J. Biol. Chem. 272:31092.
28. Kronke, M., S. Schutze, P. Scheurich, and K. Pfizenmaier. 1992. TNF signal transduction and TNF-responsive genes. Immunol. Ser. 56:189.
29. Beg, A. A., W. C. Sha, R. T. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376:167.
30. Baldwin, A. S. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649.
31. Lee, R., P. Beauparlant, H. Elford, P. Ponka, and J. Hiscott. 1997. Selective inhibition of IκBα phosphorylation and HIV-1 LTR-directed gene expression by novel antioxidant compounds. Virology 234:277.
32. Beauparlant, P., and J. Hiscott. 1996. Biological and biochemical inhibitors of the NF-κB/Rel proteins and cytokine synthesis. Cytokine Growth Factor Rev. 7:175.
33. Whitley, M. Z., D. Thanos, M. A. Read, T. Maniatis, and T. Collins. 1994. A striking similarity in the organization of the E-selectin and beta interferon gene promoters. Mol. Cell. Biol. 14:6464.
34. Perkins, N. D., R. M. Schmid, C. S. Duckett, K. Leung, N. R. Rice, and G. J. Nabel. 1992. Distinct combinations of NF-κB subunits determine the specificity of transcriptional activation. Proc. Natl. Acad. Sci. USA 89:1529.
35. Kunsch, C., S. M. Ruben, and C. A. Rosen. 1992. Selection of optimal kappa B/Rel DNA-binding motifs: interaction of both subunits of NF-κB with DNA is required for transcriptional activation. Mol. Cell. Biol. 12:4412.
36. Thanos, D., and T. Maniatis. 1995. Virus induction of human IFNβ gene expression requires the assembly of an enhanceosome. Cell 83:1091.
37. Kim, T. K., and T. Maniatis. 1997. The mechanism of transcriptional synergy of an in vitro assembled interferon-β enhanceosome. Mol. Cell 1:119.
38. Carey, M. 1998. The enhanceosome and transcriptional synergy. Cell 92:5.
39. Yoon, K., M. A. Thiede, and G. A. Rodan. 1988. Alkaline phophatase as a reporter enzyme. Gene 66:11.
40. Jones, P. L., D. Ping, and J. M. Boss. 1997. TNF-α and IL-1β regulate the murine manganese superoxide dismutase gene through a complex intronic enhancer. Mol. Cell Biol. 17:6970.
41. Vilen, B. J., J. P. Cogswell, and J. P.-Y. Ting. 1991. Stereospecific alignment of the X and Y elements is required for major histocompatibility complex class II DRA promoter function. Mol. Cell. Biol. 11:2406.
42. Schreck, R., B. Meier, D. N. Mannel, W. Droge, and P. A. Baeuerle. 1992. Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J. Exp. Med. 175:1181.
43. Thompson, J. E., R. J. Phillips, H. Erdjument-Bromage, P. Tempst, and S. Ghosh. 1995. IκB-β regulates the persistent response in a biphasic activation of NF-κB. Cell 80:573.
44. Sha, W. C., H. C. Liou, E. T. Tuomanen, and D. Baltimore. 1995. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80:321.
45. Sidhu, R. S., and A. P. Bollon. 1993. Tumor necrosis factor activities and cancer therapy: a perspective. Pharmacol. Ther. 57:79.
46. Freter, R. R., J. A. Alberta, G. Y. Hwang, A. L. Wrentmore, and C. D. Stiles. 1996. Platelet-derived growth factor induction of the intermediate-early gene MCP-1 is mediated by NF-κB and a 90-kDa phosphorylation coactivator. J. Biol. Chem. 271:17417.
47. Perkins, N. D., N. L. Edwards, C. S. Duckett, A. B. Agranoff, R. M. Schmid, and G. J. Nabel. 1993. A cooperative interaction between NF-κB and Sp1 is required for HIV-1 enhancer activation. EMBO J. 12:3551.
48. Thanos, D., and T. Maniatis. 1992. The high mobility group protein HMG 1(Y) is required for NF-κB-dependent virus induction of the human IFN-β gene. Cell 71:777.
49. Lewis, H., W. Kaszubska, J. F. DeLamarter, and J. Whelan. 1994. Cooperativity between two NF-κB complexes, mediated by high-mobility-group protein 1(Y), is essential for cytokine-induced expression of the E-selectin promoter. Mol. Cell. Biol. 14:5701.
50. John, S., R. B. Reeves, J.-X. Lin, R. Child, J. M. Leiden, C. B. Thompson, and W. J. Leonard. 1995. Regulation of cell-type-specific interleukin-2 receptor α-chain gene expression: potential role of physical interactions between Elf-1, HMG-1(Y), and NF-κB family proteins. Mol. Cell. Biol. 15:1786.
51. Yie, J., S. Liang, M. Merika, and D. Thanos. 1997. Intra- and intermolecular cooperative binding of high-mobility-group protein 1(Y) to the β-interferon promoter. Mol. Cell. Biol. 17:3649.
52. Xia, Y., M. E. Pauza, L. Feng, and D. Lo. 1997. RelB regulation of chemokine expression modulates local inflammation. Am. J. Pathol. 151:375.
53. Feuillard, J., M. Korner, M. Israel, J. Vassy, and M. Raphael. 1996. Differential nuclear localization of p50, p52, and RelB proteins in human accessory cells of the immune response in situ. Eur. J. Immunol. 26:2547.
54. Montano, M. A., K. Kripke, C. D. Norina, P. Achacoso, L. A. Herzenberg, A. L. Roy, and G. P. Nolan. 1996. NF-κB homodimer binding within the HIV initiator region and interactions with TFII-1. Proc. Natl. Acad. Sci. USA 93: 12376.
55. Fujita, T., G. P. Nolan, S. Ghosh, and D. Baltimore. 1992. Independent modes of transcriptional activation by the p50 and p65 subunits of NF-κB. Genes Dev. 6:775.
56. Brennan, P., and L. A. J. O'Neill. 1995. Effects of oxidants and antioxidants on nuclear factor κB activation in three different cell lines: evidence against a universal hypothesis involving oxygen radicals. Biochim. Biophys. Acta 1260:167.
57. Bonizzi, G., E. Dejardin, B. Piret, J. Piette, Marie-Paule, Merville, and V. Bours. 1996. Interleukin-1§ induces nuclear factor κB in epithelial cells independently of the production of reactive oxygen intermediates. Eur. J. Biochem. 242:544.
58. Pazin, M. J., P. L. Sheridan, K. Cannon, Z. Cao, J. G. Keck, J. T. Kadonaga, and K. A. Jones. 1996. NF-κB-mediated chromatin reconfiguration and transcriptional activation of the HIV-1 enhancer in vitro. Genes Dev. 10:37.
59. Kara, C. J., and L. H. Glimcher. 1991. In vivo footprinting of MHC class II genes: bare promoters in the bare lymphocyte syndrome. Science 252:709.
60. Westerheide, S. D., P. Louis-Plence, D. Ping, X.-F. He, and J. M. Boss. 1997. HLA-DMA and HLA-DMB gene expression functions through the conserved S-X-Y region. J. Immunol. 158:4812.
61. Reith, W., C. A. Siegrist, B. Durand, E. Barras, and B. Mach. 1994. Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y. Proc. Natl. Acad. Sci. USA 91:554.
62. Louis-Plence, P., C. S. Moreno, and J. M. Boss. 1997. Formation of a RFX-X2BP-NF-Y multiprotein complex on the conserved regulatory regions of HLA-class II genes. J. Immunol. 159:3899.